✦ LIBER ✦

Inhibition of HIV-1 integrase by modified oligonucleotides: Optimization of the inhibitor structure

✍ Scribed by T. A. Prikazchikova; E. M. Volkov; E. M. Zubin; E. A. Romanova; M. B. Gottikh

Book ID: 110174424
Publisher: SP MAIK Nauka/Interperiodica
Year: 2007
Tongue: English
Weight: 178 KB
Volume: 41
Category: Article
ISSN: 0026-8933
DOI: 10.1134/s0026893307010165

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Exploring the binding of HIV-1 integrase

Exploring the binding of HIV-1 integrase inhibitors by comparative residue interaction analysis (CoRIA)

✍ Devendra K. Dhaked; Jitender Verma; Anil Saran; Evans C. Coutinho 📂 Article 📅 2008 🏛 Springer-Verlag 🌐 English ⚖ 367 KB

Inhibition of HIV-1 in Cell Culture by O

Inhibition of HIV-1 in Cell Culture by Oligonucleotide-Loaded Nanoparticles

✍ Myriam Berton; Priscilla Turelli; Didier Trono; Cy Stein; Eric Allémann; Robert 📂 Article 📅 2001 🏛 Springer US 🌐 English ⚖ 155 KB

Discovery and Structure–Activity Relatio

Discovery and Structure–Activity Relationship Studies of a Unique Class of HIV-1 Integrase Inhibitors

✍ Raveendra Dayam; Tino Sanchez; Nouri Neamati 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 337 KB 👁 1 views

Inhibition of HIV-1 integrase activity b

Inhibition of HIV-1 integrase activity by synthetic peptides derived from the HIV-1 HXB2 Pol region of the viral genome

✍ Zahrah Zawahir; Nouri Neamati 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 217 KB

ChemInform Abstract: The Total Synthesis

ChemInform Abstract: The Total Synthesis of Fukiic Acid, an HIV-1 Integrase Inhibitor.

✍ Clemence Queffelec; Fabrice Bailly; Gladys Mbemba; Jean-Francois Mouscadet; Zege 📂 Article 📅 2009 🏛 John Wiley and Sons ⚖ 14 KB 👁 2 views

Development of the next generation of HI

Development of the next generation of HIV-1 integrase inhibitors: Pyrazolone as a novel inhibitor scaffold

✍ Victor Hadi; Yung-Hyo Koh; Tino Wilson Sanchez; Danielle Barrios; Nouri Neamati; 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 522 KB

HIV-1 integrase (IN), one of the essential enzymes in HIV infection, has been validated as a target for HIV treatment. While more than 20 drugs have been approved by the FDA to treat HIV/AIDS, only one drug, Raltegravir (1), was approved as an IN inhibitor. The rapid mutation of the virus, which lea